|
|
Article: Ark Thera and Health Care Logistics in Kerraboot deal.(Brief article)
- Article from:
- Pharma Marketletter
- Article date:
- October 16, 2006
CopyrightCOPYRIGHT 2006 Marketletter Publications Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
UK-based drugmaker Ark Therapeutics, a specialist health care group focused on vascular diseases and cancer, says that its medical devices subsidiary, Patient Plus, has signed a pilot distribution and marketing agreement with the USA's Health Care Logistics, in relation to its Kerraboot wound care device for the management of leg and foot ulcers. The agreement, which will run for an initial one-year period, is designed to establish the product in the USA and to allow the UK firm to collect data that supports its economic benefits. Under the terms of the deal, HCL will market Kerraboot to its existing customers in the eastern parts of the USA, which includes hospitals, ...